- Home
- MCRI vs LIVN Comparison
MCRI vs LIVN Comparison
Compare MCRI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- LIVN
- Stock Information
- Founded
- MCRI 1972
- LIVN 1987
- Country
- MCRI United States
- LIVN United Kingdom
- Employees
- MCRI N/A
- LIVN N/A
- Industry
- MCRI Hotels/Resorts
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MCRI Consumer Discretionary
- LIVN Health Care
- Exchange
- MCRI Nasdaq
- LIVN Nasdaq
- Market Cap
- MCRI 1.9B
- LIVN 2.1B
- IPO Year
- MCRI 1993
- LIVN 1993
- Fundamental
- Price
- MCRI $104.33
- LIVN $56.37
- Analyst Decision
- MCRI Hold
- LIVN Strong Buy
- Analyst Count
- MCRI 5
- LIVN 7
- Target Price
- MCRI $96.20
- LIVN $59.71
- AVG Volume (30 Days)
- MCRI 78.8K
- LIVN 774.2K
- Earning Date
- MCRI 10-22-2025
- LIVN 10-29-2025
- Dividend Yield
- MCRI 1.15%
- LIVN N/A
- EPS Growth
- MCRI N/A
- LIVN N/A
- EPS
- MCRI 4.22
- LIVN N/A
- Revenue
- MCRI $534,693,999.00
- LIVN $1,309,329,000.00
- Revenue This Year
- MCRI $6.80
- LIVN $11.29
- Revenue Next Year
- MCRI $4.13
- LIVN $6.59
- P/E Ratio
- MCRI $24.75
- LIVN N/A
- Revenue Growth
- MCRI 4.65
- LIVN 8.23
- 52 Week Low
- MCRI $69.99
- LIVN $32.48
- 52 Week High
- MCRI $113.88
- LIVN $57.35
- Technical
- Relative Strength Index (RSI)
- MCRI 61.59
- LIVN 72.54
- Support Level
- MCRI $100.02
- LIVN $54.50
- Resistance Level
- MCRI $106.75
- LIVN $56.70
- Average True Range (ATR)
- MCRI 2.21
- LIVN 1.44
- MACD
- MCRI 0.09
- LIVN 0.23
- Stochastic Oscillator
- MCRI 75.68
- LIVN 90.65
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.